Remove food supplements for containing the active substance of Viagra

Aemps, the Spanish Agency of Medicines and Health Products, has ordered the withdrawal of various food supplements of the Tenerife company Marco Cordone-Spain because they contain the active principle sildenafil, the same as Viagra, but without indicating it in the labeling, which can produce adverse reactions.
The Aemps, dependent of the Ministry of Health, explains that the withdrawal of these products occurs after the same agency banned on April 23 the marketing of the food supplement also "VX Capsules"by containing the same active ingredient.
On that occasion, this irregularity was known through the Health Department of the Territorial Delegation of Guipúzcoa, who learned about the commercialization of this product distributed by the Portuguese company Bioceutica. In this case, it has been the Consumer, Environment and Doping Group of the National Police Force that has warned the Aemps of the commercialization of the products "Bioacvit capsules", "Bioacvit Extra Forte Capsules", "Torexan Capsules", "Devit Forte Capsules", "Devit Solo Piante Capsules" and "Bull Extreme Capsules".
They are medicines, not supplements
These products contain sildenafil "in sufficient quantity to restore, correct or modify a physiological function exerting a pharmacological action", which gives it the legal status of medication. A substance that is not declared on its labeling, where a series of products of plant origin is indicated "deceptively", underlines the note of the Spanish Agency of Medicines and Health Products.
They contain sildenafil "in sufficient quantity to restore, correct or modify a physiological function exerting a pharmacological action"
Sildenafil It is indicated to restore erectile function impaired by increasing blood flow of the penis by selective inhibition of phosphodiesterase 5 (PDE-5).
Inhibitors of PDE-5 are contraindicated in patients with acute myocardial infarction, unstable angina, effort angina, heart failure, uncontrolled arrhythmias, hypotension, hypertension, stroke and severe hepatic failure, among other pathologies. In addition, these inhibitors have numerous interactions with other medications.